Itaru Endo

Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Year:

2026

Introduction: Pneumonia is a leading cause of postoperative mortality in elderly patients with ulcerative colitis (UC), and close attention should be paid to the possibility of Pneumocystis jiroveci pneumonia (PJP) in patients with immunosuppression. We present the case of a patient with severe PJP that was challenging to diagnose because of postoperative Candida sepsis complications in an elderly patient with acute severe ulcerative colitis (ASUC) with immunosuppression. Case Presentation: A 70-year-old man was transferred to our hospital and was diagnosed with ASUC. The patient underwent laparoscopic subtotal colectomy for prednisolone and granulocyte and monocyte adsorptive apheresis-resistance UC 22 days after transfer. On postoperative day (POD) 9, the central venous catheter (CVC) was removed because CVC-related blood stream infection (CRBSI) was suspected. On POD 12, fluconazole was administered for Candida parapsilosis sepsis due to CRBSI, and a septic pulmonary embolism was suspected. The patient’s hypoxemia worsened; trimethoprim-sulfamethoxazole was administered because PJP was suspected on POD 19; however, ventilatory support was started on POD 21. PJP was diagnosed based on bronchoalveolar lavage on POD 25, and high-dose prednisolone therapy was initiated. The patient was weaned off the ventilator on POD 27 and was discharged home on POD 54. Proctectomy and stapled ileal pouch-anal anastomosis were performed at 10 months postoperatively, and the patient is currently alive at 1 year and 6 months after surgery. Conclusion: Postoperative hypoxemia in elderly patients with ASUC should be considered in the differential diagnosis of PJP, even during the treatment of Candida sepsis.

Year:

2025

Background/Objectives Postoperative complications following pancreaticoduodenectomy (PD) remain high, particularly in patients with soft pancreatic texture. Abdominal aortic calcification volume (AACV), a surrogate marker of systemic arteriosclerosis, has been associated with increased surgical risk in lower gastrointestinal procedures; however, its relevance in hepatopancreatobiliary surgery has not been well established. This study aimed to evaluate the clinical significance of AACV in predicting postoperative complications after PD. Methods We retrospectively analyzed 182 patients who underwent PD for nonpancreatic malignancies at our institution between January 2007 and December 2023. AACV was measured using the SYNAPSE VINCENT 3D imaging system, assessing calcification from the renal artery to the common iliac artery bifurcations on preoperative CT. Clinical characteristics and short‐term postoperative outcomes were evaluated. Results The cohort included distal cholangiocarcinoma (57.1%), papillary carcinoma (35.7%), duodenal cancer (2.7%), IPMN (2.2%), and pancreatic neuroendocrine tumors (1.6%). Soft pancreatic texture was observed in 85.2% of patients. The median AACV was 894.5 mm 3 (range: 284.6–2951.9) and correlated weakly with age ( r = 0.377, p < 0.001). Patients with Clavien–Dindo grade≥IIIa complications had significantly higher AACV than those without (1745.9 vs. 751.9 mm 3 , p < 0.001). AACV was identified as an independent predictor of both severe complications (HR: 10.9; 95% CI: 4.44–26.3) and POPF≥Grade B (HR: 4.85; 95% CI: 2.2–10.8). Conclusion AACV is significantly associated with severe postoperative complications and clinically relevant pancreatic fistula following PD, particularly in patients with nonpancreatic malignancies. It may serve as a valuable preoperative risk predictor in this population.

Year:

2025

Over the past three decades, we have mentored a generation of young Japanese surgeons, guiding them to become internationally recognized surgeon‐scientists. Through a unique collaboration between Japanese academic institutions and our laboratories at AntiCancer Inc. and the University of California, San Diego (UCSD), these trainees engaged in immersive translational research. They mastered advanced imaging and therapeutic tools including fluorescent‐protein technology, patient‐derived orthotopic xenograft (PDOX) models, the FUCCI cell‐cycle imaging system, tumor‐targeting Salmonella typhimurium A1‐R (A1‐R), and recombinant methioninase (rMETase) to treat the methionine addiction of cancer. These technologies enabled real‐time visualization of cancer biology in vivo, accurate modeling of tumor behavior, and the development of strategies to target quiescent, treatment‐resistant cancer cells. FUCCI imaging revealed that most solid cancer cells within tumors exist in non‐cycling states, which are largely unaffected by conventional therapies. Our team explored methods to decoy these cells into vulnerable phases of the cell cycle. PDOX models provided a clinically‐relevant platform to evaluate such strategies, while A1‐R and rMETase offered novel therapeutic avenues by exploiting cancer‐specific vulnerabilities. The present review highlights the scientific advances achieved through this collaboration, but also the human story of mentorship, cultural exchange, and the formation of a lasting international academic network and permanent friendship. Many of our mentees now lead research laboratories and academic departments across Japan, continuing the cycle of innovation and global partnership. We reflect on this journey as a successful model for training surgeon‐scientists and advancing precision cancer therapy through visualization, imagination, and mentorship.

Year:

2025

Lateral lymph node dissection (LLND) is recognized as an effective treatment for reducing local recurrence in patients with locally advanced lower rectal cancer. However, the lack of standardization in techniques and anatomical landmarks remains a concern, as it may complicate the assessment of treatment efficacy. To address this, the Japan Society of Gastroenterological Surgery (JSGS) held a consensus meeting during the 77th General Meeting of the JSGS to standardize LLND techniques. In this meeting, essential anatomical landmarks for LLND were confirmed. The primary regions targeted for dissection include lymph nodes in the obturator region (designated as station 283) and those in the internal iliac region (designated as station 263). The medial boundary of LLND is defined by the uretero‐hypogastric fascia, whereas the vesico‐hypogastric fascia constitutes the central plane of dissection and serves as the medial boundary of station 283. Indicators of successful LLND completion include exposure of the sciatic nerve (lumbosacral trunk) at the bottom of the dissection, as well as exposure of the inferior vesical vessels, internal pudendal artery, and coccygeus muscle, confirming the thoroughness of the caudal part of the dissection. The consensus reached in this meeting, along with findings from several published reports cited in this report, is expected to contribute to the standardization of LLND quality.

Year:

2025

Background Liver resection for multifocal intrahepatic cholangiocarcinoma (ICC) remains controversial due to a poor prognosis, driven by aggressive tumour biology. The aim of this study was to stratify multifocal ICC patients to identify those who are likely to benefit from resection. Methods Patients who underwent upfront curative-intent hepatectomy for ICC were identified from an international multi-institutional database. Among patients with multifocal tumours, overall survival (OS) was analysed using multivariable Cox regression to identify prognostic factors. Tumour burden score (TBS) was used for stratification of multifocal ICC, with the optimal cut-off determined via restricted cubic spline (RCS) analysis. Results Of 1502 patients, 208 (13.8%) had multifocal ICC. Among them, independent predictors of prognosis included TBS (HR 1.09), ASA grade >II (HR 1.48), cirrhosis (HR 2.05), periductal infiltrating/mass forming plus periductal infiltrating morphological subtype (HR 1.58), and receipt of adjuvant chemotherapy (HR 0.59). RCS analysis identified a TBS of 7.0 as the optimal cut-off. Notably, multifocal ICC patients with a low TBS (<7.0) demonstrated comparable 3-year OS to solitary ICC patients with AJCC stage II/III. In contrast, patients with a high TBS (≥7.0) and multifocal ICC exhibited the worst prognosis (3-year OS: stage I and solitary 67.1%, stage II/III and solitary 43.2%, low TBS and multifocal 43.4%, and high TBS and multifocal 17.8% (P < 0.001)). Conclusion Whereas patients with high-TBS multifocal ICC had a poor prognosis, individuals with low-TBS multifocal ICC demonstrated survival outcomes comparable to solitary ICC patients. These findings emphasize the importance of stratifying patients by tumour burden to guide surgical decision-making and optimize treatment strategies for multifocal ICC.

Year:

2025

Purpose This study aimed to investigate the effects of the coronavirus disease 2019 pandemic on morbidity and mortality after advanced hepatectomy by surgical volume in Japan. Methods Data from patients who underwent advanced hepatectomy between 2018 and 2022 from the Japanese National Clinical Database were collected. The transition of the number of hepatectomies and changes in risk‐adjusted mortality and major complication rates based on the type of institutions certified by the Japan Society of Hepato‐Biliary‐Pancreatic Surgery were investigated. Results A total of 33 454 cases were included. The number of advanced hepatectomies gradually decreased, whereas the proportion of hepatectomies performed in certified institutions increased (from 63.4% in 2018 to 71.3% in 2022). Although the major complication rate in institution A was higher than that in institution B or noncertified institutions (16.3% vs. 14.5% vs. 13.5%), the in‐hospital mortality rate was consistently favorable in the order of institution A, institution B, and noncertified institutions (1.4% vs. 2.0% vs. 2.8%). The monthly standardized mortality and major complication ratios did not significantly increase mostly throughout the pandemic, regardless of the institution type. Conclusions The centralization to certified institutions progressed even during the pandemic. Surgical safety after advanced hepatectomy was satisfactorily maintained in any institution.

Year:

2025

Aim The purpose of this study was to assess whether the use of spray‐type anti‐adhesion material during diverting ileostomy construction could reduce the surgeon's multidimensional workload, the degree of adhesion, and the operation time in ileostomy closure. Methods Patients diagnosed with rectal cancer, who were scheduled for laparoscopic or robotic rectal surgery followed by diverting ileostomy, were single‐blindly (patient‐blind), randomly assigned to either the AdSpray™ arm or the control arm. The primary endpoint was the multidimensional workload of the ileostomy closure operator (SURG‐TLX value). Results Between January 2020 and December 2022, 126 patients were enrolled. Five patients were excluded and a total of 121 patients (control arm, n = 60; AdSpray™ arm, n = 61) were analyzed. The baseline factors were well balanced between the two arms. Regarding SURG‐TLX in ileostomy closure, operators in the AdSpray™ arm required a significantly lower overall workload than those in the control arm (AdSpray™ arm, 28.1; control arm, 58.9; p < 0.001). Mental, physical, and temporal demands, task complexity, situation stress, and distractions were significantly lower in the AdSpray™ arm ( p < 0.001). Operative time was significantly shorter in the AdSpray™ arm (AdSpray™ arm, 58 min; control arm, 65 min; p = 0.040). The degree of adhesion ( p < 0.001) and extent of intra‐abdominal adhesions ( p < 0.001) in ileostomy closure were significantly lower in the AdSpray™ arm. Conclusions The use of spray‐type anti‐adhesion material was associated with a significantly lower SURG‐TLX value, lower incidence of adhesion, less severe adhesion, and shorter operative time.

Year:

2025

Background The choice between 22‐gauge endoscopic ultrasound‐guided fine‐needle biopsy (EUS‐FNB) and EUS‐guided fine‐needle aspiration (EUS‐FNA) for histological diagnosis of type 1 autoimmune pancreatitis (AIP) is unclear. We retrospectively examined the detection rate of histological findings for AIP using EUS‐FNA/FNB. Methods Patients diagnosed with type 1 AIP using EUS‐FNB (Franseen needle) or EUS‐FNA (conventional needle) with 22‐gauge needles at our hospital between 2012 and 2023 were included in this study. AIP was diagnosed according to International Consensus Diagnostic Criteria (ICDC). The detection rates of level 1 findings, which included storiform fibrosis and/or obliterative phlebitis, and level 2 histological findings were evaluated according to the ICDC. Results The EUS‐FNB and EUS‐FNA groups included 25 and 24 patients, respectively. No significant differences in patient background were noted between the two groups. The detection rates of prominent filtration of lymphocytes and plasma cells along with fibrosis were 56.0% in the EUS‐FNB group and 12.5% in the EUS‐FNA group ( p = .001). The detection rates of more than 10 IgG4‐positive plasma cells per high‐power microscopic field were 68.0% and 29.2% in the EUS‐FNB and EUS‐FNA groups, respectively ( p = .007). The histological findings for levels 1 and 2 were significantly higher in the EUS‐FNB group (56.0% vs. 12.5%; p = .001). Mild pancreatitis was observed in the EUS‐FNB group; however, no other serious adverse events occurred. Conclusion The 22‐gauge EUS‐FNB yielded a higher rate of histological findings than 22‐gauge EUS‐FNA, suggesting that 22‐gauge EUS‐FNB is suitable and safe for the histological diagnosis of type 1 AIP.

Year:

2024

Background/Purpose This study clarifies the short‐ and long‐term outcomes of liver resection with hepatic vein (HV) reconstruction for liver tumors and identifies the risk factors for poor outcome. Methods We contacted 263 specialized centers in Japan and collected data on this surgical procedure. Patient characteristics, surgical procedures, and outcomes were then analyzed. Results A total of 187 patients were enrolled from 36 institutions. Grade C post‐hepatectomy liver failure (PHLF) and in‐hospital mortality were 3.2% and 1.6%, respectively. The median overall survival (OS) and recurrence‐free survival (RFS) were 49.9 and 9.8 months, respectively. Surgical outcomes, OS and RFS did not differ among three types of liver tumors, colorectal liver metastasis (CRLM) ( n = 127), hepatocellular carcinoma ( n = 27), and intrahepatic cholangiocarcinoma ( n = 27). Patients with CRLM and seven or more courses of preoperative chemotherapy had significantly worse OS. Compared with HV reconstruction for securing liver remnant (LR) function ( n = 148), reconstruction of the only main HV remaining in the LR ( n = 39) had significantly worse short‐term outcomes, but did not result in increased mortality, and showed equivalent OS and RFS. Conclusions Liver resection with HV reconstruction can be achieved safely and contributes to a relatively good long‐term outcome for patients with advanced liver malignancies.

Year:

2024

Year:

2024

Year:

2023

Collaborators (13)

Bas Groot Koerkamp

Full professor

Erasmus University Rotterdam

NETHERLANDS
View details

Taizo Hibi

-

JAPAN
View details

Luca Antonio Aldrighetti

Professore/Primario

Università Vita Salute San Raffaele

ITALY
View details

Tomoharu Yoshizumi

Kyushu University

JAPAN
View details

Takashi Akiyoshi

The Cancer Institute Hospital

JAPAN
View details

Timothy M. Pawlik

The Ohio State University Wexner Medical Center

UNITED STATES
View details

Masafumi Nakamura

-

JAPAN
View details

Shoji Kubo

-

JAPAN
View details

Andrea RUZZENENTE

University of Verona

ITALY
View details

Kentaro Miyake

Assistant Professor

Yokohama National University

JAPAN
View details

Yutaro Kato

Fujita Health University

JAPAN
View details

Guillaume Martel

University of Ottawa

CANADA
View details

Kazuteru Monden

Fukuyama City Hospital

JAPAN
View details